M&A

The Takeovers Panel has agreed to hear Mayne Pharma's latest dispute with Cosette over the US drug maker's attempts to walk away from their $672 million merger agreement and extended the timeline for completing the deal.

Mayne Pharma has secured an extension of the deadline for securing Foreign Investment Review Board approval of its $672 million tie-up with US drug maker Cosette.

MinterEllison has lured a leading corporate law partner away from King & Wood Mallesons to lead the firm's private equity practice.

Cosette plans to appeal a ruling that rejected its bid to terminate an agreement to merge with Mayne Pharma, as the US drug company also refuses to agree to conditions needed to win Foreign Investment Review Board approval for the tie-up.

AGL has agreed to sell the lion's share of its equity stake in Tilt Renewables to the Queensland Investment Corporation and Australia's sovereign wealth fund for $750 million.

Mayne Pharma is not walking away from US drug maker Cosette's proposed takeover without a fight, filing an application with the Takeovers Panel to force Cosette to agree to the conditions needed to win FIRB approval for the $672 million deal.

A French engineering and consulting group involved in some of Australia's largest public transport projects has acquired unlisted Australian multi-disciplinary engineering firm BG&E Group.

Several Apache Corporation units have failed to block Santos from withdrawing admissions in a long-running fight over $83 million in tax credits related to Apache's $2.1 billion sale of certain assets, with a judge finding Apache’s prejudice arguments were “significantly overstated”.

Global real estate investment giant Colliers has boosted its presence in South Australia by acquiring a leading Adelaide-based urban development consultancy.

Mayne Pharma is facing a new hurdle in its plans to merge with US drug maker Cosette, with the Treasurer flagging it may block the $672 million deal.